General Information of the Compound
| Compound ID |
CP0575201
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(dimethylamino)-N-[3-[(1S,3S,4S,7S,9S)-9-[3-[[3-(dimethylamino)benzoyl]amino]phenyl]-3,9-dimethyl-2,5,8-trioxa-10-azatricyclo[5.2.1.04,10]decan-3-yl]phenyl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H41N5O5
|
||||||||||||||||||
| Molecular Weight |
647.776
|
||||||||||||||||||
| Canonical SMILES |
CN(C)c1cccc(c1)C(=O)Nc1cccc(c1)[C@]1(C)O[C@H]2CO[C@@H]3N2[C@H]1O[C@@]3(C)c1cccc(NC(=O)c2cccc(c2)N(C)C)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H41N5O5/c1-37(26-13-9-15-28(21-26)39-33(44)24-11-7-17-30(19-24)41(3)4)35-43-32(23-46-35)47-38(2,36(43)48-37)27-14-10-16-29(22-27)40-34(45)25-12-8-18-31(20-25)42(5)6/h7-22,32,35-36H,23H2,1-6H3,(H,39,44)(H,40,45)/t32-,35-,36-,37-,38-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XGLXQYSUNAPXDT-HJEOPMBSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1